Skip to content

Truth or Dare; Artificial Blastocoel Collapse Using Laser Before Blastocyst's Vitrification Versus Non-laser Usage

Truth or Dare; Artificial Blastocoel Collapse of Human Blastocysts Before Vitrification

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04124809
Enrollment
10
Registered
2019-10-11
Start date
2019-01-05
Completion date
2021-10-01
Last updated
2022-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blastocyst Disintegration

Keywords

blastocyst, Vitrification, artificial collapse, survival rate

Brief summary

: This prospective randomized observational study aimed to compare behavior of artificially collapsed blastocysts to blastocysts that were vitrified without artificial collapse.

Detailed description

One arm study of 60 patients with sibling blastocysts divided into 2 groups: Study group (artificially laser-collapsed blastocysts; n=71) & control group (blastocysts were vitrified without laser collapse; n=66) then reexpansion speed and survival rate was assessed immediately & at 140 min after thawing and compared between two groups.

Interventions

DEVICElaser assisted collapse

Apply 1-2 pulses of laser using the Saturn between 2 adjacent trophectoderm cells away from the inner cell mass in the blastocysts

Sponsors

Hawaa Fertility Center
CollaboratorOTHER
Benha University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Masking description

only the investigator knew the procedure provided for each case

Intervention model description

patients with sibling blastocysts divided into 2 groups: Study group (artificially laser-collapsed blastocysts; n=71) & control group (blastocysts were vitrified without laser collapse; n=66) then reexpansion speed and survival rate was assessed immediately & at 140 min after thawing and compared between two groups.

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 37 Years
Healthy volunteers
No

Inclusion criteria

* Age limit 20-37 At least 6 good quality blastocysts per case. expansion rate 3-4

Exclusion criteria

* bad quality blastocysts expansion rate less than 3

Design outcomes

Primary

MeasureTime frameDescription
survival rateimmediately after thawingsurvival rate will be assessed immediately after thawing and compared between both groups.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026